Cargando…
PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer
Inhibition of WEE1 kinase by AZD1775 has shown promising results in clinical cancer trials, but markers predicting AZD1775 response are lacking. Here we analysed AZD1775 response in a panel of human breast cancer (BC) cell lines by global proteome/transcriptome profiling and identified two groups of...
Autores principales: | Brunner, Andrä, Suryo Rahmanto, Aldwin, Johansson, Henrik, Franco, Marcela, Viiliäinen, Johanna, Gazi, Mohiuddin, Frings, Oliver, Fredlund, Erik, Spruck, Charles, Lehtiö, Janne, Rantala, Juha K, Larsson, Lars-Gunnar, Sangfelt, Olle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338058/ https://www.ncbi.nlm.nih.gov/pubmed/32628111 http://dx.doi.org/10.7554/eLife.57894 |
Ejemplares similares
-
Ex vivo assessment of targeted therapies in a rare metastatic epithelial–myoepithelial carcinoma
por: Mäkelä, Rami, et al.
Publicado: (2020) -
K63-linked ubiquitylation induces global sequestration of mitochondria
por: Richard, Thibaud J. C., et al.
Publicado: (2020) -
FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma
por: Suryo Rahmanto, Aldwin, et al.
Publicado: (2016) -
CDK-mediated activation of the SCF(FBXO28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer
por: Cepeda, Diana, et al.
Publicado: (2013) -
PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma
por: Vidarsdottir, Linda, et al.
Publicado: (2021)